Group 1: Company Performance and Investments - The company has exited its investment in "Pumice" and adjusted its fair value according to the acquisition price by the end of 2024 [1] - The company has not participated in the privatization of Hong Kong 00982 [1] - The company focuses on high-end manufacturing, healthcare, internet and emerging technologies, consumption upgrades, new energy, and energy conservation as key investment areas [3] Group 2: Financial Reporting and Valuation - The company does not directly hold shares in IPO companies but participates through subsidiary-managed partnership funds, with a small proportion of total fund shares [4] - The fair value of the company's investments is measured based on the net asset value of the funds as of June 30, 2025 [4] - The company has not directly held shares in Bona Film Group, and any losses reported will not affect the company's financial statements [4] Group 3: Market Conditions and Strategic Direction - The company's stock price is influenced by macroeconomic factors and market sentiment, leading to fluctuations [4] - The company is committed to steady operational management and enhancing internal value for shareholders [3] - The company has been in the investment and management business for over 10 years, focusing on strategic emerging industries [5]